Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02388581 | First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL | unknown | Phase 2 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT01626963 | Single-port Versus Conventional Laparoscopic Colorectal Surgery | unknown | Phase 1 / Phase 2 | 50 | North Tees and Hartlepool NHS Foundation TrustOTHER | 1 | Mar 24, 2016 | clinicaltrials |
| NCT02375581 | Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer | unknown | Phase 2 | 130 | First People's Hospital of HangzhouOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT02715362 | A Study of GPC3 Redirected Autologous T Cells for Advanced HCC(GPC3-CART) | unknown | Phase 1 / Phase 2 | 30 | Shanghai GeneChem Co., Ltd.INDUSTRY | 1 | Mar 22, 2016 | clinicaltrials |
| NCT02702323 | Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study | unknown | Phase 2 / Phase 3 | 40 | Zhejiang Cancer HospitalOTHER | 0 | Mar 8, 2016 | clinicaltrials |
| NCT02688023 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01551641 | Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer | unknown | Phase 2 | 180 | Changzhou No.2 People's HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT02683655 | Study of Apatinib in Metastatic Esophageal Cancer | unknown | Phase 2 | 40 | Huai'an First People's HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01509911 | A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment | unknown | Phase 2 | 99 | Tiltan Pharma Ltd.INDUSTRY | 2 | Feb 5, 2016 | clinicaltrials |
| NCT02672488 | Metformin Plus Sorafenib for Advanced HCC | unknown | Phase 2 | 82 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT02665702 | Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas | unknown | Phase 2 | 76 | Fudan UniversityOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT02466906 | RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer | unknown | Phase 2 | 60 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT01675999 | Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer(ECKINOXE) | unknown | Phase 2 | 186 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT01257360 | Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III)(NEO-RIT) | unknown | Phase 2 | 59 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 1 | Jan 13, 2016 | clinicaltrials |
| NCT02068131 | Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT02632006 | Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 40 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT02632188 | Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 60 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT02632201 | Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis | unknown | Phase 1 / Phase 2 | 40 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT02638857 | Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 60 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT02202928 | Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | Dec 28, 2015 | clinicaltrials |
| NCT01242124 | Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy | unknown | Phase 2 / Phase 3 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01618474 | Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients | unknown | Phase 2 | 100 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01715532 | Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT02634502 | Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT02133079 | Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 20 | Cure&Sure Biotech Co., LTDINDUSTRY | 1 | Dec 11, 2015 | clinicaltrials |
| NCT02623153 | Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer | unknown | Phase 2 | 200 | Tianshu LiuOTHER | 0 | Dec 7, 2015 | clinicaltrials |
| NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | unknown | Phase 2 | 46 | Sun Yat-sen UniversityOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT02409199 | A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer | unknown | Phase 2 / Phase 3 | 66 | Shanghai Zhongshan HospitalOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT02291744 | A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients | unknown | Phase 2 | 130 | Fudan UniversityOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT02051868 | International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel(InterAACT) | unknown | Phase 2 | 80 | Royal Marsden NHS Foundation TrustOTHER | 3 | Nov 4, 2015 | clinicaltrials |
| NCT02586753 | Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus | unknown | Phase 2 | 2 | Mianyang Central HospitalOTHER | 0 | Oct 26, 2015 | clinicaltrials |
| NCT01088204 | Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer(COACT_1001) | unknown | Phase 2 | 204 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01882946 | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Northwest BiotherapeuticsINDUSTRY | 1 | Oct 7, 2015 | clinicaltrials |
| NCT02549911 | HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis | unknown | Phase 2 | 40 | Zhejiang Cancer HospitalOTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT02528526 | Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm(OXY1A) | unknown | Phase 1 / Phase 2 | 69 | University of ZurichOTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT02525237 | Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 30 | Qingdao Municipal HospitalOTHER | 0 | Aug 17, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02515734 | A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab(DEEPER) | unknown | Phase 2 | 360 | Japan Clinical Cancer Research OrganizationOTHER | 0 | Aug 5, 2015 | clinicaltrials |
| NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | unknown | Phase 2 / Phase 3 | 360 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 3, 2015 | clinicaltrials |
| NCT02510378 | Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases | unknown | Phase 2 | 47 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 29, 2015 | clinicaltrials |
| NCT02509169 | Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 60 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Jul 27, 2015 | clinicaltrials |
| NCT02504229 | DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment | unknown | Phase 2 | 80 | Beijing Biohealthcare Biotechnology Co.,LtdINDUSTRY | 1 | Jul 21, 2015 | clinicaltrials |
| NCT02490709 | Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy | unknown | Phase 2 | 86 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 7, 2015 | clinicaltrials |
| NCT02488707 | Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).(MISS-TRICR) | unknown | Phase 2 | 250 | Mansoura UniversityOTHER | 1 | Jul 2, 2015 | clinicaltrials |
| NCT00674167 | The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma | unknown | Phase 2 | 21 | National University Hospital, SingaporeOTHER | 1 | Jun 12, 2015 | clinicaltrials |
| NCT01818973 | Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer | unknown | Phase 2 | 45 | Sun Yat-sen UniversityOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT02452853 | HR Combined With FOLFOX4 for HCC With PVTT | unknown | Phase 2 | 51 | Sun Yat-sen UniversityOTHER | 0 | May 25, 2015 | clinicaltrials |
| NCT01211210 | Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer(FOWARC) | unknown | Phase 2 / Phase 3 | 495 | Sun Yat-sen UniversityOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT01679340 | A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery | unknown | Phase 2 | 160 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT02413476 | Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy | unknown | Phase 2 / Phase 3 | 120 | wei boOTHER | 0 | May 19, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Mar 25, 2016source: clinicaltrials